Repatha: A Molecule's Global Launch

In March 2015, Amgen was preparing to launch Repatha, a new molecule that had demonstrated a remarkable ability to treat high cholesterol. The global brand team lead, Alex Shamoun, responsible for the product launch outside of the United States, was contemplating launch goals and developing a plan to achieve them.